Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of Ascendis Pharma's TransCon IL-2 beta/gamma?
TransCon IL-2 beta/gamma is a recombinant protein commercialized by Ascendis Pharma, with a leading Phase II program in Human Papillomavirus...
Data Insights
Risk adjusted net present value: What is the current valuation of Ascendis Pharma's TransCon IL-2 beta/gamma?
TransCon IL-2 beta/gamma is a recombinant protein commercialized by Ascendis Pharma, with a leading Phase II program in Cervical Cancer....